Inspire Medical Systems Inc
NYSE:INSP
Cash Flow Statement
Cash Flow Statement
Inspire Medical Systems Inc
Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | |||||||||||||||||||||||||||
Net Income |
(18)
|
(20)
|
(21)
|
(21)
|
(22)
|
(24)
|
(25)
|
(29)
|
(33)
|
(41)
|
(57)
|
(59)
|
(57)
|
(57)
|
(47)
|
(47)
|
(42)
|
(43)
|
(44)
|
(50)
|
(45)
|
(44)
|
(41)
|
(33)
|
(21)
|
(16)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
3
|
3
|
3
|
|
Stock-Based Compensation |
0
|
0
|
1
|
1
|
1
|
3
|
4
|
5
|
6
|
8
|
9
|
11
|
13
|
16
|
20
|
23
|
26
|
30
|
36
|
44
|
52
|
60
|
69
|
75
|
82
|
0
|
|
Other Non-Cash Items |
1
|
2
|
2
|
2
|
2
|
2
|
3
|
4
|
6
|
8
|
10
|
13
|
14
|
18
|
21
|
24
|
28
|
31
|
38
|
45
|
53
|
61
|
71
|
78
|
84
|
88
|
|
Cash Interest Paid |
1
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
3
|
2
|
2
|
1
|
0
|
0
|
0
|
|
Change in Working Capital |
1
|
1
|
(0)
|
(1)
|
1
|
(2)
|
(8)
|
(5)
|
(7)
|
(4)
|
(3)
|
(10)
|
(11)
|
(10)
|
(8)
|
(3)
|
(7)
|
(13)
|
(14)
|
(3)
|
2
|
3
|
2
|
(21)
|
(41)
|
(41)
|
|
Cash from Operating Activities |
(16)
N/A
|
(17)
-7%
|
(19)
-12%
|
(19)
-2%
|
(19)
+4%
|
(23)
-24%
|
(30)
-29%
|
(29)
+2%
|
(33)
-12%
|
(37)
-12%
|
(49)
-34%
|
(55)
-12%
|
(53)
+4%
|
(49)
+8%
|
(34)
+31%
|
(25)
+26%
|
(20)
+19%
|
(22)
-12%
|
(18)
+19%
|
(7)
+62%
|
12
N/A
|
23
+99%
|
34
+48%
|
27
-22%
|
25
-8%
|
35
+41%
|
|
Investing Cash Flow | |||||||||||||||||||||||||||
Capital Expenditures |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(2)
|
(3)
|
(3)
|
(2)
|
(2)
|
(2)
|
(4)
|
(5)
|
(5)
|
(5)
|
(5)
|
(4)
|
(7)
|
(9)
|
(12)
|
(15)
|
(19)
|
(24)
|
(32)
|
|
Other Items |
(7)
|
(7)
|
(2)
|
(89)
|
(83)
|
(67)
|
(110)
|
(17)
|
(41)
|
10
|
83
|
58
|
89
|
22
|
(10)
|
46
|
34
|
34
|
21
|
(11)
|
(11)
|
(10)
|
10
|
(128)
|
(271)
|
(279)
|
|
Cash from Investing Activities |
(8)
N/A
|
(7)
+8%
|
(2)
+66%
|
(89)
-3 707%
|
(83)
+7%
|
(68)
+19%
|
(111)
-64%
|
(20)
+82%
|
(44)
-118%
|
8
N/A
|
81
+945%
|
55
-32%
|
87
+57%
|
18
-79%
|
(15)
N/A
|
41
N/A
|
29
-29%
|
29
-1%
|
17
-42%
|
(17)
N/A
|
(20)
-14%
|
(22)
-12%
|
(6)
+74%
|
(146)
-2 517%
|
(295)
-102%
|
(311)
-5%
|
|
Financing Cash Flow | |||||||||||||||||||||||||||
Net Issuance of Common Stock |
25
|
0
|
113
|
113
|
182
|
182
|
71
|
72
|
3
|
3
|
128
|
130
|
134
|
137
|
14
|
15
|
15
|
14
|
15
|
256
|
260
|
264
|
276
|
35
|
31
|
27
|
|
Net Issuance of Debt |
0
|
8
|
8
|
8
|
8
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(3)
|
(25)
|
(25)
|
0
|
(21)
|
0
|
0
|
0
|
|
Other |
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(2)
|
(3)
|
(3)
|
(17)
|
(18)
|
|
Cash from Financing Activities |
26
N/A
|
8
-67%
|
121
+1 333%
|
121
0%
|
190
+58%
|
182
-4%
|
71
-61%
|
71
+0%
|
2
-97%
|
3
+59%
|
128
+4 013%
|
130
+2%
|
134
+3%
|
137
+2%
|
14
-90%
|
15
+11%
|
15
-3%
|
14
-3%
|
12
-20%
|
232
+1 902%
|
235
+1%
|
238
+1%
|
252
+6%
|
31
-88%
|
14
-56%
|
9
-35%
|
|
Change in Cash | |||||||||||||||||||||||||||
Effect of Foreign Exchange Rates |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
(0)
|
|
Net Change in Cash |
2
N/A
|
(15)
N/A
|
99
N/A
|
12
-88%
|
88
+651%
|
91
+3%
|
(71)
N/A
|
22
N/A
|
(74)
N/A
|
(26)
+65%
|
160
N/A
|
131
-18%
|
168
+28%
|
106
-37%
|
(35)
N/A
|
32
N/A
|
24
-24%
|
21
-13%
|
10
-52%
|
208
+1 968%
|
227
+9%
|
239
+5%
|
280
+17%
|
(88)
N/A
|
(256)
-191%
|
(267)
-4%
|
|
Free Cash Flow | |||||||||||||||||||||||||||
Free Cash Flow |
(16)
N/A
|
(17)
-5%
|
(19)
-12%
|
(20)
-2%
|
(19)
+3%
|
(24)
-25%
|
(31)
-32%
|
(32)
-1%
|
(36)
-12%
|
(39)
-11%
|
(51)
-30%
|
(57)
-12%
|
(56)
+3%
|
(52)
+6%
|
(38)
+27%
|
(30)
+23%
|
(25)
+17%
|
(27)
-9%
|
(23)
+16%
|
(14)
+40%
|
2
N/A
|
11
+360%
|
19
+67%
|
8
-57%
|
1
-87%
|
3
+220%
|